QVT Financial LP
13F filer · CIK 0001290162Reported May 15, 2026
Net buyer this quarter
13F portfolio value$1.66BU.S. long equity reported on 13F
Positions6325 new · 9 closed
Net flow last quarter+$57.2MBuys minus sells
Top 10 positions weight74.3%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q1 2026Reported May 15, 202663 positions | |||||
| $697M | 51.04% | 3.49% | -4.7% | Q4 2021 | |
| $64.8M | 4.75% | 4.02% | Not reported | Q1 2024 | |
| $47.6M | 3.49% | 0.02% | +8.8% | Q3 2015 | |
| $37.3M | 2.73% | 11.51% | +10.6% | Q2 2021 | |
| $36.6M | 2.68% | Not reported | +48.3% | Q4 2025 | |
| $29.8M | 2.19% | Not reported | +0.8% | Q3 2021 | |
| $28.1M | 2.06% | 0.51% | Not reported | Q2 2017 | |
| $26.5M | 1.94% | Not reported | Not reported | Q2 2015 | |
| $23.9M | 1.75% | 0.00% | +0.4% | Q2 2025 | |
| $23M | 1.69% | 0.00% | +18.9% | Q2 2014 | |
| $23M | 1.68% | Not reported | Not reported | Q3 2019 | |
| $19.2M | 1.41% | 2.66% | Not reported | Q3 2019 | |
| $16.9M | 1.23% | 0.00% | +1980.4% | Q4 2025 | |
| $15.9M | 1.17% | 9.78% | Not reported | Q4 2024 | |
| $15.4M | 1.13% | Not reported | Not reported | Q2 2021 | |
| $12.5M | 0.92% | 7.47% | -11.5% | Q3 2025 | |
| $10.8M | 0.79% | 0.18% | +13.4% | Q4 2016 | |
| $10.2M | 0.75% | 0.13% | Not reported | Q2 2021 | |
| ATFOLDAmicus Therapeutics, Inc. | $10.1M | 0.74% | 0.22% | New | Q1 2026 |
| $9.8M | 0.72% | 0.15% | New | Q1 2026 | |
| RARAAQReal Asset Acquisition Corp. | $8.01M | 0.59% | Not reported | New | Q1 2026 |
| $7.8M | 0.57% | 1.38% | New | Q1 2026 | |
| $6.84M | 0.50% | 0.05% | Not reported | Q2 2024 | |
| $5.91M | 0.43% | 0.11% | +7.5% | Q4 2025 | |
| $5.49M | 0.40% | 0.00% | +0.8% | Q4 2025 | |
| $5.39M | 0.39% | 0.32% | +640.6% | Q4 2025 | |
| $5.34M | 0.39% | 5.71% | +21.7% | Q3 2024 | |
| $3.81M | 0.28% | 0.01% | Not reported | Q2 2017 | |
| $3.05M | 0.22% | Not reported | Not reported | Q3 2019 | |
| $2.99M | 0.22% | 0.00% | +28.4% | Q4 2024 | |
| $2.67M | 0.20% | Not reported | New | Q1 2026 | |
| $2.42M | 0.18% | Not reported | +64.6% | Q2 2025 | |
| $2.38M | 0.17% | 0.15% | Not reported | Q2 2017 | |
| $1.53M | 0.11% | 0.00% | +56.2% | Q4 2025 | |
| $1.44M | 0.11% | 0.00% | +28.3% | Q3 2025 | |
| $1.44M | 0.11% | 0.11% | Not reported | Q3 2023 | |
| $1.26M | 0.09% | 0.33% | Not reported | Q4 2016 | |
| $1.23M | 0.09% | 0.00% | New | Q1 2026 | |
| $1.19M | 0.09% | 0.00% | New | Q1 2026 | |
| $1.15M | 0.08% | Not reported | -87.8% | Q4 2025 | |
| $1.12M | 0.08% | 0.00% | New | Q1 2026 | |
| $1.04M | 0.08% | 0.00% | Not reported | Q1 2016 | |
| $1.03M | 0.08% | 0.01% | +31.3% | Q3 2025 | |
| $1.03M | 0.08% | 0.00% | New | Q1 2026 | |
| $1.02M | 0.07% | 0.00% | +312.6% | Q4 2025 | |
| $1.01M | 0.07% | 0.00% | New | Q1 2026 | |
| $864K | 0.06% | 0.00% | Not reported | Q2 2015 | |
| $769K | 0.06% | 0.00% | -2.0% | Q1 2025 | |
| $699K | 0.05% | Not reported | +7.3% | Q4 2025 | |
| $669K | 0.05% | 0.00% | +35.4% | Q4 2025 | |
| Q4 2025Reported Feb 13, 202647 positions | |||||
| $573M | 49.10% | 3.72% | -10.2% | Q4 2021 | |
| $49.8M | 4.27% | 10.41% | +12.4% | Q2 2021 | |
| $45.5M | 3.90% | 0.02% | -10.0% | Q3 2015 | |
| $43.4M | 3.72% | 4.02% | Not reported | Q1 2024 | |
| $31.5M | 2.70% | 0.51% | Not reported | Q2 2017 | |
| $30.5M | 2.62% | Not reported | Not reported | Q3 2021 | |
| $26.3M | 2.26% | Not reported | New | Q4 2025 | |
| $25.5M | 2.19% | 0.00% | +692.6% | Q2 2025 | |
| $24.1M | 2.07% | Not reported | Not reported | Q3 2019 | |
| $23M | 1.97% | 8.44% | +5.5% | Q3 2025 | |
| $22M | 1.89% | Not reported | Not reported | Q2 2015 | |
| $20.8M | 1.78% | 0.00% | Not reported | Q2 2014 | |
| $13.1M | 1.12% | Not reported | Not reported | Q2 2021 | |
| $12.7M | 1.09% | Not reported | New | Q4 2025 | |
| $11M | 0.94% | 2.69% | Not reported | Q3 2019 | |
| $10.6M | 0.91% | 9.79% | Not reported | Q4 2024 | |
| $8.89M | 0.76% | 0.16% | +557.1% | Q4 2016 | |
| $7M | 0.60% | 4.70% | +41.5% | Q3 2024 | |
| $6.31M | 0.54% | 0.05% | Not reported | Q2 2024 | |
| $6.11M | 0.52% | 0.10% | New | Q4 2025 | |
| $6.09M | 0.52% | 0.00% | New | Q4 2025 | |
| $5.89M | 0.51% | 0.13% | Not reported | Q2 2021 | |
| $4.39M | 0.38% | 0.01% | -39.9% | Q2 2017 | |
| $2.76M | 0.24% | 0.00% | +8.5% | Q4 2024 | |
| $2.22M | 0.19% | Not reported | +161.4% | Q2 2025 | |
| $1.92M | 0.16% | 0.13% | Not reported | Q3 2023 | |
| $1.85M | 0.16% | 0.16% | Not reported | Q2 2017 | |
| $1.41M | 0.12% | 0.33% | Not reported | Q4 2016 | |
| $1.35M | 0.12% | 0.00% | Not reported | Q1 2025 | |
| $1.22M | 0.10% | 0.00% | -25.5% | Q3 2025 | |
| $1.06M | 0.09% | 0.00% | New | Q4 2025 | |
| $1.03M | 0.09% | 0.00% | New | Q4 2025 | |
| $995K | 0.09% | 0.04% | New | Q4 2025 | |
| $700K | 0.06% | Not reported | New | Q4 2025 | |
| $685K | 0.06% | 0.00% | +27.8% | Q2 2022 | |
| $670K | 0.06% | 0.00% | New | Q4 2025 | |
| $660K | 0.06% | 0.00% | -69.9% | Q1 2025 | |
| $621K | 0.05% | 0.01% | +33.7% | Q3 2025 | |
| $605K | 0.05% | 0.00% | -21.1% | Q3 2025 | |
| $555K | 0.05% | 0.00% | +41.6% | Q3 2025 | |
| $399K | 0.03% | 0.00% | New | Q4 2025 | |
| $360K | 0.03% | 0.00% | New | Q4 2025 | |
| $296K | 0.03% | 0.00% | New | Q4 2025 | |
| $284K | 0.02% | 0.00% | New | Q4 2025 | |
| $254K | 0.02% | 0.00% | -62.1% | Q3 2025 | |
| $206K | 0.02% | 0.00% | Not reported | Q1 2022 | |
| $205K | 0.02% | 0.00% | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 202540 positions | |||||
| $445M | 31.37% | 4.26% | Not reported | Q4 2021 | |
| TBTRMLTourmaline Bio, Inc. | $103M | 7.27% | 8.39% | Not reported | Q4 2023 |
| $47.7M | 3.36% | 9.70% | Not reported | Q2 2021 | |
| $45.8M | 3.23% | 0.02% | -23.7% | Q3 2015 | |
| $37.5M | 2.65% | 4.42% | Not reported | Q1 2024 | |
| $28.8M | 2.03% | Not reported | Not reported | Q3 2021 | |
| $24.1M | 1.70% | Not reported | Not reported | Q3 2019 | |
| $18.2M | 1.28% | Not reported | Not reported | Q2 2015 | |
| $17.9M | 1.27% | Not reported | New | Q3 2025 | |
| $14.8M | 1.04% | Not reported | Not reported | Q2 2021 | |
| $14.7M | 1.04% | 0.07% | +5.9% | Q2 2025 | |
| $10.8M | 0.76% | 2.69% | Not reported | Q3 2019 | |
| $8.33M | 0.59% | 9.79% | Not reported | Q4 2024 | |
| $7.45M | 0.53% | 0.05% | Not reported | Q2 2024 | |
| $6.4M | 0.45% | 0.01% | -33.4% | Q2 2017 | |
| $5.9M | 0.42% | 0.13% | Not reported | Q2 2021 | |
| $3.22M | 0.23% | 0.00% | -88.6% | Q2 2025 | |
| $2.67M | 0.19% | 0.00% | +20.4% | Q4 2024 | |
| $2.55M | 0.18% | 0.16% | Not reported | Q3 2023 | |
| $2.41M | 0.17% | 3.35% | Not reported | Q3 2024 | |
| $2.34M | 0.16% | 0.00% | -32.1% | Q1 2025 | |
| $1.68M | 0.12% | 0.33% | Not reported | Q4 2016 | |
| $1.57M | 0.11% | 0.02% | Not reported | Q4 2016 | |
| $1.47M | 0.10% | 0.18% | Not reported | Q2 2017 | |
| $1.45M | 0.10% | Not reported | -84.7% | Q1 2018 | |
| $1.27M | 0.09% | 0.00% | New | Q3 2025 | |
| $1.14M | 0.08% | 0.00% | -74.4% | Q4 2024 | |
| $1.02M | 0.07% | Not reported | +129.6% | Q2 2025 | |
| $1.02M | 0.07% | 0.09% | Not reported | Q2 2025 | |
| $995K | 0.07% | 0.00% | Not reported | Q1 2025 | |
| $803K | 0.06% | 0.00% | New | Q3 2025 | |
| $625K | 0.04% | 0.00% | Not reported | Q2 2022 | |
| $557K | 0.04% | 0.01% | New | Q3 2025 | |
| $501K | 0.04% | 0.00% | New | Q3 2025 | |
| $487K | 0.03% | 0.00% | New | Q3 2025 | |
| CCFLTConfluent, Inc. | $342K | 0.02% | 0.02% | New | Q3 2025 |
| $302K | 0.02% | 0.00% | New | Q3 2025 | |
| $271K | 0.02% | 0.00% | -32.9% | Q2 2025 | |
| $270K | 0.02% | 0.00% | +23.6% | Q2 2021 | |
| $216K | 0.02% | 0.00% | Not reported | Q1 2022 | |
| Q2 2025Reported Aug 14, 202533 positions | |||||
| $331M | 29.50% | 4.31% | -55.3% | Q4 2021 | |
| $53.4M | 4.76% | 0.02% | +0.7% | Q3 2015 | |
| $36.6M | 3.26% | 9.70% | +22.2% | Q2 2021 | |
| TBTRMLTourmaline Bio, Inc. | $34.5M | 3.07% | 8.39% | +46.2% | Q4 2023 |
| $27.8M | 2.48% | 4.42% | Not reported | Q1 2024 | |
| $27.8M | 2.48% | Not reported | Not reported | Q3 2021 | |
| $23.9M | 2.13% | 0.00% | New | Q2 2025 | |
| $23.3M | 2.07% | Not reported | Not reported | Q3 2019 | |
| $17.7M | 1.58% | Not reported | Not reported | Q2 2015 | |
| $12.9M | 1.15% | 2.70% | Not reported | Q3 2019 | |
| $12.2M | 1.09% | 0.00% | New | Q2 2025 | |
| $10.9M | 0.97% | Not reported | Not reported | Q2 2021 | |
| $9.71M | 0.86% | 0.08% | New | Q2 2025 | |
| $9.52M | 0.85% | Not reported | +848.0% | Q1 2018 | |
| $8.2M | 0.73% | 9.79% | +2.2% | Q4 2024 | |
| $7.67M | 0.68% | 0.05% | Not reported | Q2 2024 | |
| $7.18M | 0.64% | 0.02% | Not reported | Q2 2017 | |
| $5.54M | 0.49% | 0.13% | Not reported | Q2 2021 | |
| $2.62M | 0.23% | 0.01% | -50.0% | Q4 2024 | |
| $2.41M | 0.21% | 3.35% | +39.5% | Q3 2024 | |
| $2.4M | 0.21% | 0.16% | Not reported | Q3 2023 | |
| $2.31M | 0.21% | 0.00% | Not reported | Q4 2024 | |
| IINFAInformatica LLC | $2.21M | 0.20% | 0.09% | Not reported | Q1 2024 |
| $2.01M | 0.18% | 0.05% | New | Q2 2025 | |
| $1.68M | 0.15% | 0.00% | +65.9% | Q1 2025 | |
| $1.32M | 0.12% | 0.33% | Not reported | Q4 2016 | |
| $1.17M | 0.10% | 0.20% | Not reported | Q2 2017 | |
| $1.13M | 0.10% | 0.09% | New | Q2 2025 | |
| $656K | 0.06% | 0.00% | New | Q2 2025 | |
| $402K | 0.04% | Not reported | New | Q2 2025 | |
| $263K | 0.02% | Not reported | New | Q2 2025 | |
| $216K | 0.02% | 0.00% | Not reported | Q2 2021 | |
| MTMRSNMersana Therapeutics, Inc. | $18.5K | 0.00% | 1.26% | Not reported | Q2 2021 |
Premium opens every quarter this fund has filed